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AbStrACt Eruptive melanocytic nevi are an unusual phenomenon 
characterized by sudden onset of multiple melanocytic nevi on previ-
ously unaffected skin. The majority of case reports have linked this 
condition with blistering skin disease or immunosuppression. There 
are only three reports of eruptive nevi developing on the palms and 
/or soles in healthy individuals. Herein we present the clinical and der-
moscopic features of two cases of  eruptive acral nevi that developed 
in healthy individuals in the absence of any recognizable underlying 
disease and review the current literature of eruptive nevi.
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INtroDUCtIoN
Eruptive melanocytic nevi (EMN) represent a 
rare phenomenon characterized by sudden onset 
of multiple melanocytic nevi on previously unaf-
fected skin. The etiology of these lesions is largely 
unknown, although their appearance is associated 
with a number of primary skin conditions, mainly 
severely blistered skin (1-6). It has also been ob-
served in renal or bone marrow transplant patients 
or in cases of AIDS (7), primary adrenocortical insuf-
ficiency (8), trauma (9), cutaneous mastocytosis (10), 
Langerhans cell histiocytosis (11), melanoma, and 
psoralen plus ultraviolet A therapy (12). Recently, a 
number of cases of EMN in patients under treatment 
with biologics and immunosuppressive drugs have 
been reported (1,13-15).
Herein we present the clinical and dermoscopic 
features of two cases of eruptive acral nevi that de-
veloped in healthy individuals in the absence of any 
recognizable underlying disease or association with 
a medication. 
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CASE 1
A 45-year-old man sought consultation because 
of the recent onset of asymptomatic slightly pig-
mented lesions on his palms. The first lesion had ap-
peared about 5 months earlier with subsequent de-
velopment of a further 2 similar lesions on the right 
and left palm (Figure 1). The patient was otherwise 
healthy and had no history of recent drug intake or 
persistent medication. 
Dermoscopic examination of the lesions revealed 
absence of characteristic features associated with 
acral melanocytic tumors such as parallel furrow pat-
terns or other variants. Instead, the lesions presented 
a repetitive pattern of a whitish-skin colored back-
ground and subtle, discrete, light-brown globules 
and dots resembling a spoked wheel or concentric-
like structures, which are sometimes seen in basal 
cell carcinomas. Since these equivocal features did 
not allow for a definitive diagnosis, biopsy was per-
formed. Histopathology revealed a symmetric intra-
dermal melanocytic proliferation composed of round 
and polygonal melanocytes (nevus cells) which were 
nested or grouped in band-like formations without 
epidermal (junctional) involvement and with matura-
tion in deeper portions of the lesion. A final diagnosis 
of an intradermal nevus was established. In order to 
rule out an underlying cause of the eruptive occur-
rence of acral nevi in our patient, we performed rou-
tine laboratory analysis, radiography of the chest, and 
sonography of the abdomen and lymph nodes, which 
were all unremarkable and within normal ranges. 
CASE 2
An otherwise healthy 40-year-old woman visited 
our clinic due to the sudden onset of a pigmented 
macule on her right sole, which she had first noticed 
approximately 3 months earlier. Dermatological ex-
amination revealed pigmented macules ranging 
from 3 mm to 13 mm, with a semicircular lesion lo-
cated on the fourth finger of the right foot (Figure 2). 
Dermoscopy of the acral lesions showed parallel fur-
row- and lattice-like patterns, thus confirming clinical 
diagnosis of eruptive acral nevi. A punch biopsy was 
performed to support the clinical diagnosis. Histopa-
thology revealed pagetoid spreading of melanocytes 
in localized, well-circumscribed nests throughout 
the epidermis, with dermal maturation confirming 
the diagnosis of an acral compound nevus. Labora-
tory tests and imaging (radiography of the chest and 
ultrasound examination of the abdomen and lymph 
nodes) revealed no pathological findings. 
DISCUSSIoN
The eruptive development of multiple nevi has 
been linked to a number of underlying causes includ-
ing different internal diseases, cutaneous skin disor-
ders, medications, and immunosuppression (5,16-19).
Figure 1. (a) Clinical image of delicate, slightly elevated le-
sions on the palms with subtle pigmentation on the surface. 
(b) Dermoscopic image of the lesion revealed whitish-pink 
background and subtle structures resembling concentric-
like features. (c) Histopathologic examination revealed a 
symmetrical intradermal well-delineated melanocytic le-
sion composed of round and polygonal melanocytes (ne-
vus cells) which were nested or grouped in band-like for-
mations without epidermal (junctional) propagation and 
with clear histological maturation in deeper portions of the 
lesion corresponding to diagnosis of intradermal nevi.
Figure 2. (a) Clinical image of pigmented macules from 3 
mm to 13 mm in diameter, with a semicircular pigmented 
lesion on the fourth finger of the right foot. (b) Dermoscop-
ic evaluation of the lesion revealed a benign parallel furrow 
pattern. (c) Dermoscopic evaluation of the lesion revealed 
a lattice-like pattern corresponding to diagnosis of acral 
nevus. (d) Histopathologic examination revealed pagetoid 
spreading of melanocytes in localized, well-circumscribed 
nests throughout the epidermis, with dermal maturation 
confirming the diagnosis of acral nevi.
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ENMs do not show a predilection for a specific age, 
sex, and race. The majority of eruptive nevi develop 
on the trunk, while sudden development on the gla-
brous skin of the palms and soles has been reported 
only seldomly. As of this writing, only 3 cases of EMN 
on the palms and soles have been reported. The first 
case is that of an 8-year-old boy who developed mul-
tiple nevi on the soles after receiving chemotherapy 
for acute lymphatic leukemia (17), while Binder et al. 
(16) reported the case of a 22-year-old woman with 
acral EMN associated with Crohn disease. The 3rd case 
described a 25-year-old woman with Crohn disease 
in treatment with prednisone and azathioprine (5). In 
all 3 cases, the development of EMN was associated 
with an underlying co-morbidity and with the intake 
of immunosuppressive medications. 
In contrast to the 3 published cases, our 2 patients 
with localized EMN on the palms or soles did not suf-
fer from any associated disease nor did they take any 
type of medication at the time of diagnosis and in the 
two years of follow-up. Additionally, in contrast to 
the previously reported cases which referred mainly 
to young adults, our patients were adults in the fifth 
decade of life in both cases, when the development 
of nevi is rather unusual. Therefore, in order to ex-
clude association with an underlying co-morbidity 
or intake of medications, detailed history and clinical 
examination of patients with sudden onset of EMN is 
recommended.
There are several hypotheses explaining the un-
derlying pathomechanism in the development of 
EMN. For bullous diseases, changes in local growth 
factors such as stem-cell activating factors may con-
tribute to the sudden proliferation of melanocytes 
(1,5). Similar changes involving local growth factors 
have been also implicated in the development of 
drug-associated EMN. Others emphasize the role for 
melanocyte-stimulating hormones in the develop-
ment of EMN (1).
Furthermore, there are some lines of evidence 
that certain individuals are genetically predisposed 
to subclinical nest formation of melanocytes in the 
skin, which proliferate due to immunosuppression 
and give rise to the sudden formation of nevi at pre-
viously unaffected skin sites (1,3,18-20).
CoNCLUSIoN 
Despite these hypotheses, which are mainly based 
on EMN in the context of either localized or system 
immune-suppression, the mechanism leading to the 
development of acral EMN in healthy individuals re-
mains to be further elucidated. However, there are 
some lines of evidence indicating that the eccrine 
ducts function as a stem cell niche. It may therefore 
be speculated that an activation via increased expres-
sion of melanocortin 5 receptor, which is one of the 
receptors known to bind melanocyte-stimulating 
hormone, may play a role in their development (1-5).
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